Long noncoding RNA Breast cancer antiestrogen resistance 4 is associated with cancer progression and its significant prognostic value
Authors:
- 7 December 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (8) , 12956-12963
Abstract
Breast cancer antiestrogen resistance 4 (BCAR4) is a novel long noncoding RNA. It was originally identified in a screen for genes responsible for the development of resistance to antiestrogens in breast cancer cells and plays a major role in various tumors. However, the clinical diagnostic role of BCAR4 in tumors is not completely understood. This current meta‐analysis aimed to comprehensively explore the potential role of BCAR4 as a prognostic biomarker in a number of cancers. Five public databases PubMed, EMBASE, Web of Science, Wiley Online Library, and Medline were used to search for articles. Nine studies comprising 1,293 patients were included in this meta‐analysis. The results of analysis showed that BCAR4 expression in human cancer was significantly associated with poor overall survival (hazard ratio [HR] = 1.98, confidence interval [CI]: [1.71–2.29]), p < 0.00001, and high BCAR4 expression was associated with clinical stage (OR and its 95% CI was 3.30 [1.99–5.46], p < 0.00001), distant metastasis (OR = 3.83, 95% CI: 2.15–6.82, p < 0.00001), and lymph node metastasis (OR and its 95% CI was 2.91 [1.62–5.25], p = 0.0004) in patients with cancer. Furthermore, the results revealed the prognostic significance of BCAR4 in gastrointestinal malignancy, breast cancer, and osteosarcoma (HR and its 95% CI were 2.05 [1.56–2.68], p < 0.00001; 1.78 [1.46–2.16], p < 0.00001; and 2.47 [1.41–4.34], p < 0.00001, respectively). This meta‐analysis indicated the potential value of BCAR4 as a biomarker for predicting a poor prognosis in patients with cancer.Keywords
This publication has 20 references indexed in Scilit:
- Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcriptionTumor Biology, 2016
- Long non-coding RNA UCA1 is a predictive biomarker of cancerOncotarget, 2016
- Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysisBMJ Open, 2015
- lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine SignalsCell, 2014
- Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell linesInternational Journal of Cancer, 2012
- Non-coding RNAs as regulators of gene expression and epigeneticsCardiovascular Research, 2011
- Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancerBritish Journal of Cancer, 2010
- Performance of the trim and fill method in the presence of publication bias and between‐study heterogeneityStatistics in Medicine, 2007
- Functionality or transcriptional noise? Evidence for selection within long noncoding RNAsGenome Research, 2007
- Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: a systematic reviewEarly Human Development, 2000